SHS appoints Sascha Alilovic as managing partner
Germany-based healthcare and technology investor SHS has announced the appointment of Sascha Alilovic to the position of managing partner, succeeding Reinhilde Spatscheck, who founded the firm in 1993.
Alilovic joined SHS as a partner in 2018, but has been assisting the GP with exit transactions and fundraising since 2017, the firm said in a statement. He has experience in healthcare transactions, and was head of corporate finance and corporate development at Germany-based biopharmaceutical company MorphoSys prior to joining SHS.
SHS focuses on growth investments in the healthcare sector, particularly in medical technology and life sciences. It is currently investing from its fifth fund, which held a final close in July 2019 on €130m.
More on People
CapMan Managing Partner Johan Pålsson to depart
Pålsson resigns from management effective immediately; to stay as buyout partner until February 2024
Capvis grapples with EUR 1bn fundraise amid team exodus
Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023
Golding adds insurance expertise with hire for institutional clients team
Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater